Skip to main content

Ileal Conduit

The ileal conduit is the most commonly performed urinary diversion following radical cystectomy, although its use varies by population and center.[1][2] It is an incontinent diversion in which a 15–20 cm segment of distal ileum serves as a passive conduit from the ureters to an external collection device via an abdominal stoma.[3] It is intended to drain continuously, rather than act as a storage reservoir; kinking or obstruction can still impair drainage.

Popularized by Eugene Bricker after World War II, it became the standard of care for incontinent urinary diversion in the 1950s once effective adhesive stoma appliances became available, and has remained the most frequently performed urinary diversion worldwide for > 70 years.[1][4]

Indications​

Ileal conduit is an established option after cystectomy for cancer and for selected refractory benign lower-tract disease. Choice depends on comorbidity, renal/hepatic function, available bowel, support for stoma care, and patient preference—not age or one creatinine cutoff alone.[5][6]

It is often suitable when a continent reconstruction's catheterization or training demands are impractical. In multiple sclerosis, a French multicenter retrospective cohort of 211 selected patients reported improved urinary quality of life and fewer UTI hospitalizations after diversion, with early complications in 42%; this remains major surgery.[7]

Severe renal or hepatic impairment limits continent bowel reservoirs, but creatinine >2 mg/dL is not a universal exclusion threshold for every diversion. Ileal conduit still carries an absorptive/metabolic burden. Active bowel disease, short bowel, or damaged/irradiated ileum may preclude use of the proposed segment and require another reconstruction. Cutaneous ureterostomy may be considered in frail patients when avoiding bowel is a priority.[6]

Surgical Technique​

Key steps​

  1. Isolation of a 15–20 cm distal ileal segment with preservation of mesenteric blood supply
  2. Restoration of bowel continuity (ileoileal anastomosis)
  3. Ureteroileal anastomosis (Bricker or Wallace — see below)
  4. Stoma maturation through the abdominal wall, typically right lower quadrant — see Stoma Site Marking for the preoperative WOC-nurse marking workflow that drives long-term stomal outcomes

Ureteroileal anastomosis — Bricker vs Wallace​

TechniqueConstructionPractical considerations
BrickerSeparate end-to-side ureteral anastomoses to the conduitAllows separate treatment of unequal ureteral lengths.
WallaceSpatulated ureters joined into a shared plate and then to the conduitA stricture at the common outlet can affect both upper tracts.

These are technical distinctions, not a universal ranking of stricture risk. Comparative cohorts have different selection and follow-up, and results conflict.[8][9][10]

Bricker and Wallace anastomosesOriginal schematic · v2026-09-11 · Clinical review pending

Bricker joins each ureter separately to bowel; Wallace joins spatulated ureters into a shared plate before the bowel anastomosis. A shared outlet can endanger both upper tracts; this drawing does not rank outcomes. (Original WARWIKI schematic; see the figure source record and review limits.)

Comparative findings vary by study and patient selection; technique choice should not rest on a single small cohort.[8][9][10] A 96-patient retrospective robotic cohort found no statistically significant differences in strictures, complications, or readmissions; it does not establish equivalence.[11]

The Ren 2025 comparison is subject to a June 2026 expression of concern concerning reference reliability. It should not support technique preference while that concern remains unresolved; the notice is not a retraction.[12]

Distal Ureter: Perfusion and Reach​

In the retrospective Das 2024 cohort (366 patients; 711 anastomoses), 35 patients developed strictures affecting 40 anastomoses. Greater distal resection was associated with lower stricture odds, adjusted OR 0.73 (95% CI 0.58–0.92). Resection lengths were 2.3 versus 1.65 cm in non-stricturing versus stricturing anastomoses. This association does not establish an optimal resection length or prove that additional resection itself prevents strictures.[13]

An earlier 463-patient cohort found no independent association between resection length and stricture. Preserve adventitial blood supply and construct a well-perfused, tension-free anastomosis; do not sacrifice reach simply to meet a length target. Perfusion assessment supplements, rather than replaces, those principles.[14][15]

Core technical principles (irrespective of technique)​

  • Spatulate the distal end of each ureter to widen the anastomotic lumen.[1][9]
  • Minimize periureteral dissection — preserve adventitial blood supply; never strip the ureter.[15]
  • Tension-free mucosa-to-mucosa anastomosis with fine absorbable suture (4-0 or 5-0 polyglactin), running or interrupted.[1][9]
  • Temporary ureteral stents are commonly used across the anastomoses. Select the device and removal timing according to drainage, healing, and the operative protocol; 10–14 days is not a universal rule.[1]

Complications​

Complications accumulate with time. In a historical series of 131 patients surviving at least five years, 87 (66%) had late conduit-related complications; among those surviving beyond 15 years, the reported rate was 94%. These survivor-cohort estimates are not an individual patient forecast.[16]

Early (within 90 days)[1]​

  • Urine leak / urinoma
  • Urinary obstruction
  • Postoperative fluid collections (hematoma, lymphocele, abscess)
  • Fistula formation
  • Wound infection

Late[1][16][17]​

ComplicationRate
Ureteroileal anastomotic stricture5–14%
Stomal complications (including stenosis)About 15–24% in the cited cohorts
Renal/upper-tract functional or morphological complicationsAbout 20–27%; definitions vary
Urolithiasis9–15% (38% after 15 yr)
Symptomatic UTI / pyelonephritis23%
Bowel complications20–24%
Ureteroarterial fistulaRare but life-threatening

Mayo Clinic series (Shimko 2011, n = 1,057; ileal or colonic conduits): 60.8% experienced diversion-related complications. The reported mean of 2.3 was among the 643 patients with complications, not all 1,057 patients. Distribution: bowel 20.3%, renal 20.2%, infectious 16.5%, stomal 15.4%, urolithiasis 15.3%.[17]

Metabolic Consequences​

Intestinal diversions cause characteristic metabolic derangements:[18][19]

  • Hyperchloremic metabolic acidosis from ammonium chloride absorption and bicarbonate wasting — may require oral bicarbonate supplementation
  • Vitamin B12 deficiency risk depends on the ileal segment used and underlying absorption; preserve terminal ileum where feasible. EAU recommends annual B12 measurement after bowel diversion.[20]
  • One retrospective comparative cohort reported metabolic abnormalities in 21% of its ileal-conduit group; this is not a universal rate.

For full pharmacologic management see Vitamin B12 supplementation, Urinary acidifiers & alkalinizers, and Mucus management.

Quality of Life — vs Other Diversions​

The ileal-conduit-vs-neobladder QoL comparison is nuanced:

  • Meta-analyses generally show marginally better QoL with neobladder for physical / role / social functioning and global health, but neobladder patients experience more urinary symptoms (incontinence, need for self-cath).[21][22][23]
  • When matched for age and comorbidities, global health is often similar; ileal-conduit patients report better long-term urinary function.[23][24][25]
  • In women, a meta-analysis of four studies (283 patients) detected no significant overall QoL difference; wide confidence intervals and observational evidence do not prove equivalence.[26]
  • Patient acceptance can be good, including in older patients, but counseling should address appliance care, leakage, body image, and available support.[5]

Comparison with Other Diversions​

FeatureIleal conduitOrthotopic neobladderContinent cutaneous reservoir
EmptyingContinuous drainage to an applianceTimed urethral emptying; catheterization may be neededScheduled catheterization through a stoma
Main practical burdenAppliance/stoma careContinence training, nocturnal leakage, retentionReliable lifelong catheter access and mucus care
Shared concernsRenal deterioration, obstruction, infection, stones, metabolic effectsSame, plus storage/emptying problemsSame, plus channel/continence-mechanism problems

There is no randomized comparison establishing one diversion as best overall. Differences in age, comorbidity, selection, and follow-up complicate renal and quality-of-life comparisons.[23][24][25][6] In the 281-patient Nieuwenhuijzen cohort, late complications were lower after ileal conduit, largely because of fewer uncomplicated UTIs; late major complications did not differ significantly.[19]

Long-Term Surveillance​

Lifelong surveillance is essential given the high cumulative complication burden:[16][27]

  • Renal function (serum creatinine, eGFR)
  • Upper-tract imaging for hydronephrosis and urolithiasis
  • Annual serum vitamin B12
  • Metabolic panel for acidosis
  • Stoma assessment by wound / ostomy nurse
  • Cancer surveillance per primary-disease protocol

In a Medicare claims cohort of 1,565 patients, renal failure/impairment was estimated in more than 16% after urinary diversion. Obstruction and renal impairment were more common in the conduit group, illustrating why a universal claim of “least renal decline” is inappropriate.[27] Functional follow-up remains necessary even after oncologic surveillance becomes less frequent.

See Also​

References​

1. Kobayashi K, Goel A, Coelho MP, et al. "Complications of ileal conduits after radical cystectomy: interventional radiologic management." Radiographics. 2021;41(1):249–267. doi:10.1148/rg.2021200067

2. Lowrance WT, Rumohr JA, Clark PE, et al. "Urinary diversion trends at a high-volume single American tertiary care center." J Urol. 2009;182(5):2369–2374. doi:10.1016/j.juro.2009.07.026

3. Khosla AA, Mendhiratta N, Jatwani K. "Urinary diversion after cystectomy for bladder cancer." JAMA Oncol. 2025. doi:10.1001/jamaoncol.2025.3644

4. Omar K, Khan NS, Shariat SF, et al. "Urinary diversion." In: Blandy's Urology, 3rd Edition. 2019;Chapter 22. ISBN: 9781118863374.

5. Siddiqui KM, Izawa JI. "Ileal conduit: standard urinary diversion for elderly patients undergoing radical cystectomy." World J Urol. 2016;34(1):19–24. doi:10.1007/s00345-015-1706-1

6. European Association of Urology. EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. 2026. Urinary diversion and patient selection. Disease management.

7. Chkir S, Michel F, Akakpo W, et al. "Non-continent urinary diversion (ileal conduit) as salvage therapy in patients with refractory lower urinary tract dysfunctions due to multiple sclerosis." Urology. 2022;168:216–221. doi:10.1016/j.urology.2022.06.014

8. Kouba E, Sands M, Lentz A, Wallen E, Pruthi RS. "A comparison of the Bricker versus Wallace ureteroileal anastomosis in patients undergoing urinary diversion for bladder cancer." J Urol. 2007;178(3 Pt 1):945–948. doi:10.1016/j.juro.2007.05.030

9. Liu L, Chen M, Li Y, et al. "Technique selection of Bricker or Wallace ureteroileal anastomosis in ileal conduit urinary diversion: a strategy based on patient characteristics." Ann Surg Oncol. 2014;21(8):2808–2812. doi:10.1245/s10434-014-3591-z

10. Krafft U, Mahmoud O, Hess J, et al. "Comparative analysis of Bricker versus Wallace ureteroenteric anastomosis and identification of predictors for postoperative ureteroenteric stricture." Langenbecks Arch Surg. 2022;407(3):1233–1240. doi:10.1007/s00423-021-02413-4

11. Carreno GL, Fu H, Messer J. "Comparison of perioperative outcomes between Bricker and Wallace anastomosis techniques in robotic-assisted radical cystectomy with intracorporeal diversion." World J Urol. 2025;43(1):415. doi:10.1007/s00345-025-05781-4

12. Frontiers Editorial Office. Expression of concern: comparative analysis of ureteroileal anastomotic stricture rates: Bricker versus Wallace techniques in ileal conduit urinary diversion—a single-surgeon study with BMI-matched design and long-term follow-up excluding cancer recurrence bias. Front Oncol. 2026;16:1912670. Published June 30, 2026. doi:10.3389/fonc.2026.1912670. Publisher notice in PMC.

13. Das A, Zeng E, Risk M, et al. Shorter ureters lead to fewer strictures following cystectomy and urinary diversion. Urology. 2024;184:272-277. doi:10.1016/j.urology.2023.12.005

14. Richards KA, Cohn JA, Large MC, et al. The effect of length of ureteral resection on benign ureterointestinal stricture rate in ileal conduit or ileal neobladder urinary diversion following radical cystectomy. Urol Oncol. 2015;33(2):65.e1-8. doi:10.1016/j.urolonc.2014.05.015

15. Li Y, Zhuang Q, Hu Z, et al. A modified ureteroileal anastomosis technique for Bricker urinary diversion. Urology. 2011;78(5):1191-5. doi:10.1016/j.urology.2011.07.001

16. Madersbacher S, Schmidt J, Eberle JM, et al. "Long-term outcome of ileal conduit diversion." J Urol. 2003;169(3):985–990. doi:10.1097/01.ju.0000051462.45388.14

17. Shimko MS, Tollefson MK, Umbreit EC, et al. "Long-term complications of conduit urinary diversion." J Urol. 2011;185(2):562–567. doi:10.1016/j.juro.2010.09.096

18. Lenis AT, Lec PM, Chamie K, Mshs MD. "Bladder cancer: a review." JAMA. 2020;324(19):1980–1991. doi:10.1001/jama.2020.17598

19. Nieuwenhuijzen JA, de Vries RR, Bex A, et al. "Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions." Eur Urol. 2008;53(4):834–842. doi:10.1016/j.eururo.2007.09.008

20. European Association of Urology. EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. 2026. Functional follow-up after urinary diversion. Follow-up.

21. Shi H, Yu H, Bellmunt J, et al. "Comparison of health-related quality of life (HRQoL) between ileal conduit diversion and orthotopic neobladder based on validated questionnaires: a systematic review and meta-analysis." Qual Life Res. 2018;27(11):2759–2775. doi:10.1007/s11136-018-1902-8

22. Cerruto MA, D'Elia C, Siracusano S, et al. "Systematic review and meta-analysis of non-RCTs on health-related quality of life after radical cystectomy using validated questionnaires: better results with orthotopic neobladder versus ileal conduit." Eur J Surg Oncol. 2016;42(3):343–360. doi:10.1016/j.ejso.2015.10.001

23. Cerruto MA, D'Elia C, Siracusano S, et al. "Health-related quality of life after radical cystectomy: a cross-sectional study with matched-pair analysis on ileal conduit vs ileal orthotopic neobladder diversion." Urology. 2017;108:82–89. doi:10.1016/j.urology.2017.06.022

24. Kern SQ, Speir RW, Tong Y, et al. "Longitudinal health-related quality of life after open radical cystectomy: comparison of ileal conduit, Indiana pouch, and orthotopic neobladder." Urology. 2021;152:184–189. doi:10.1016/j.urology.2020.12.036

25. Gellhaus PT, Cary C, Kaimakliotis HZ, et al. "Long-term health-related quality of life outcomes following radical cystectomy." Urology. 2017;106:82–86. doi:10.1016/j.urology.2017.03.053

26. Xing W, Zeng S, Xu Z, Xing S, Liu Q. "Comparison of health-related quality of life between ileal conduit diversion and orthotopic neobladder in women: a meta-analysis." Front Oncol. 2022;12:862884. doi:10.3389/fonc.2022.862884

27. Gilbert SM, Lai J, Saigal CS, Gore JL. "Downstream complications following urinary diversion." J Urol. 2013;190(3):916–922. doi:10.1016/j.juro.2013.03.026